Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Fintepla 2.2 mg/mL oral solution {equilateral_black_triangle}

Active Ingredient:
fenfluramine hydrochloride
Company:  
UCB Pharma Limited See contact details
ATC code: 
N03AX26
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 24 Apr 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
UCB Pharma Limited
Company image
Address
208 Bath Road, Slough, Berkshire, SL1 3WE
Medical Information Direct Line
+44 (0) 1753 777 100
Medical Information e-mail
[email protected]
Telephone
+ 44 (0) 1753 534655